Wednesday−Friday, December 11–13
8.75 CME/CE Credits
CME/CE Accredited Session
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025
Supported by Opioid Analgesic REMS Program Companies
Non-CME Industry Theater
Urine Trouble: Navigating Uncomplicated UTIs in the Primary Care Setting
Sponsored by GSK
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
VEOZAH™ (fezolinetant) For the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause
Sponsored by Astellas Pharma US, Inc.
CME/CE Accredited Session
Non-CME Industry Theater
Data-Driven Decisions: Obesity, CVD, & Treatment (With Interactive Gaming)
Sponsored by Novo Nordisk
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Primary care at the forefront of Cardiovascular-Renal-Metabolic diseases
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Opportunities to Reduce the Rising Tide of Cardiovascular Disease Through Better LDL-C Management
Sponsored by Family Heart Foundation
CME/CE Accredited Session
Preventive Cardiology: A Roadmap for Primary Care Clinicians
CME/CE Accredited Session
Pride in Practice: Empowering LGBTQIA+ Health and Wellbeing
Non-CME Industry Theater
Recognizing and Addressing the Risks of Shifting Epidemiology of Adult Pneumococcal Disease
Sponsored by Merck & Co., Inc.
CME/CE Accredited Session
CME/CE Accredited Session
Bridging the Gap: Clinician-Patient Communication and Bias Perspectives
Non-CME Industry Theater
The Continuum of Heart Failure
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Non-CME Industry Theater
Early Diagnosis of Alpha-1 Antitrypsin Deficiency To Help Patient Outcomes
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
CME/CE Accredited Session
Non-CME Industry Theater
Could a GLP-1 RA be the Correct Answer for Your Adult Patients With T2D and ASCVD?
Sponsored by Novo Nordisk